New hope for tough breast cancer: adding pill to chemo before surgery

NCT ID NCT04335669

Summary

This study is testing whether adding the oral chemotherapy drug capecitabine to standard carboplatin-based chemotherapy improves outcomes for patients with early triple negative breast cancer before surgery. The main goal is to see if this combination helps more patients achieve a complete response where no cancer is found in the breast tissue after treatment. Researchers are also checking if the treatment works differently depending on specific genetic features of the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aalborg Universitetshospita

    Aalborg, 9000, Denmark

  • Academical Hospital, Department of Oncology

    Uppsala, 753 09, Sweden

  • Capio S:t Göran Hospital, Department of Oncology

    Stockholm, 112 19, Sweden

  • Centralsjukhuset i Kristianstad

    Kristianstad, Skåne County, 291 85, Sweden

  • Gävle hospital, Department of Oncology

    Gävle, 803 24, Sweden

  • Halmstad Hospital, Department of Surgery

    Halmstad, 302 33, Sweden

  • Karlstad Hospital

    Karlstad, 652 30, Sweden

  • Nordsjællands Hospital

    Hillerød, 3400, Denmark

  • Norrland University Hospital, Department of Oncology

    Umeå, 907 37, Sweden

  • Regionsjælland Næstved Sygehus

    Næstved, 4700, Denmark

  • Rigshospitalet

    Copenhagen, 2100, Denmark

  • Ryhov Hospital

    Jönköping, 551 85, Sweden

  • Sahlgrenska University Hospital, Department of Oncology

    Gothenburg, 413 46, Sweden

  • Skåne University Hospital, Department of Oncology

    Malmo, 20501, Sweden

  • Sundsvall hospital

    Sundsvall, 851 86, Sweden

  • Sydvestjysk Sygehus

    Esbjerg, 6700, Denmark

  • Södersjukhuset, Department of Oncology

    Stockholm, 118 61, Sweden

  • Södra Älvsborgs Hospital

    Borås, 501 82, Sweden

  • Sønderborg sygehus

    Sønderborg, 6300, Denmark

  • Vejle Hospital

    Vejle, Region Syd, 7100, Denmark

  • Vejle syghus

    Vejle, 7100, Denmark

  • Västmanlands Hopsital Västerås

    Västerås, 721 89, Sweden

  • Växjö Hospital, Department of Oncology

    Vaxjo, 352 34, Sweden

  • Örebro University Hospital, Department of Oncology

    Örebro, 701 85, Sweden

Conditions

Explore the condition pages connected to this study.